Forzest
Forzest Price range: $ 167,00 through $ 296,00
Back to products
Fosfomycin
Fosfomycin Price range: $ 42,00 through $ 336,00

Fosamax

Price range: $ 55,00 through $ 507,00

Fosamax is a highly effective medication primarily used to treat and prevent osteoporosis in postmenopausal women. This medication belongs to a class of drugs known as bisphosphonates, which work by slowing bone loss while increasing bone density. It is also indicated to increase bone mass in men with osteoporosis and to treat those affected by Paget’s disease of the bone. By strengthening the skeletal system, Fosamax significantly helps reduce the risk of fractures in the hip and spine. Additionally, it is used to manage bone loss caused by the long-term use of certain steroid medications.

Active substance: Alendronate
SKU: Fosamax Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Fosamax belongs to a class of non-hormonal medications known as bisphosphonates, which inhibit osteoclast-mediated bone resorption. It is a prescription-only pharmaceutical product indicated primarily for the treatment and prevention of structural bone loss associated with osteoporosis. Administration of this medication must strictly follow specific medical rules to ensure optimal systemic absorption and minimize gastrointestinal mucosal risks.

This overview summarizes the key clinical data, administration rules, and potential pharmacological interactions associated with oral alendronate sodium treatment in the United States.

Key Medication Profile

Drug name Fosamax
Active ingredient (INN) Alendronate sodium
Therapeutic class Bisphosphonates (Bone resorption inhibitors)
Dosage form Oral tablet
Route of administration Oral
Prescription status Prescription (Rx) only

Clinical and Pharmacological Overview

Main uses: Fosamax is indicated for the treatment of osteoporosis in postmenopausal women to reduce the incidence of fractures, including hip and spinal fractures. It is also prescribed to increase bone mass in men with osteoporosis, as well as to prevent osteoporosis in postmenopausal women at risk of developing skeletal loss. Additionally, the medication is approved for the treatment of glucocorticoid-induced osteoporosis in men and women receiving systemic corticosteroids equivalent to 7.5 mg or more of prednisone daily, and for the treatment of Paget’s disease of bone in affected patients requiring active therapy.

How the drug works: At the cellular level, alendronate sodium binds preferentially to hydroxyapatite crystals within the mineralized bone matrix. During active bone remodeling, osteoclasts internalize the bisphosphonate compound, which disrupts intracellular enzymatic pathways involved in osteoclast activity and survival. By inhibiting osteoclast-mediated bone resorption, Fosamax decreases overall bone turnover while osteoblasts continue to form new matrix. This mechanism leads to a progressive increase in bone mineral density (BMD) and improved structural integrity of trabecular and cortical bone over time.

Dosing schedule: Dosing regimens vary based on the specific condition being managed under medical supervision. For the treatment of postmenopausal osteoporosis or male osteoporosis, the standard dosage is 70 mg taken once weekly or 10 mg taken once daily. For osteoporosis prevention, the recommended regimen is 35 mg once weekly or 5 mg once daily. Paget’s disease typically requires a higher dosage of 40 mg daily for a period of six months. Fosamax must be taken immediately upon arising for the day with a full glass of plain water (6 to 8 ounces). Patients must not lie down for at least 30 minutes after ingestion and until after their first food of the day.

Practical tips: Proper administration timing is essential for this medication due to its low baseline oral bioavailability. Take the tablet first thing in the morning before consuming any beverage, food, or other prescription or over-the-counter medications. Plain tap or bottled water is the only liquid permitted; mineral water, juice, coffee, and tea significantly impair drug absorption. Do not chew, suck, or crush the tablet, as localized release can cause severe esophageal mucosal irritation. Remaining fully upright in a sitting or standing position prevents the medication from lodging in the upper digestive tract.

What happens in the body: Oral bioavailability of alendronate is low, averaging approximately 0.6% to 0.7% under fasting conditions when taken 30 minutes prior to food intake. Ingestion of food or mineral water simultaneously with or shortly after administration reduces bioavailability by up to 60% or completely eliminates absorption. Protein binding in plasma is approximately 78%. Unabsorbed drug is excreted unchanged in the feces, whereas absorbed alendronate is rapidly redistributed into bone tissue or excreted unchanged by the kidneys via glomerular filtration. The terminal half-life of alendronate in human bone tissue exceeds 10 years, reflecting extremely slow clearance from the mineralized skeleton.

What to avoid while taking it: Avoid all beverages other than plain water at the time of administration. Calcium-rich foods, dairy products, antacids, and oral mineral supplements containing calcium, magnesium, or aluminum directly bind alendronate in the gastrointestinal tract and must be withheld for at least 30 minutes following administration. While low-to-moderate alcohol consumption does not trigger a direct chemical reaction with alendronate, chronic or heavy alcohol intake can accelerate bone loss, reduce calcium absorption, and exacerbate gastric mucosal irritation.

Compatibility with other medicines: Concomitant administration of oral calcium supplements, antacids, and multivitamin preparations containing divalent or trivalent cations impairs the systemic absorption of alendronate. Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or naproxen, can potentiate gastrointestinal mucosal toxicity and increase the risk of gastric irritation when taken alongside bisphosphonates. Intravenous aminoglycosides combined with bisphosphonates may increase the risk of developing hypocalcemia. Always inform your healthcare provider of all prescription medications, vitamins, and supplements currently in use.

Adverse reactions: Common adverse events associated with Fosamax involve the upper gastrointestinal tract, including heartburn, acid regurgitation, esophageal erosions, abdominal pain, and dyspepsia. Musculoskeletal discomfort, including bone, joint, or muscle pain, is also reported. Less common side effects include headache, dizziness, constipation, diarrhea, flatulence, and peripheral swelling. Rarely, severe hypocalcemia, osteonecrosis of the jaw (ONJ), and atypical subtrochanteric or diaphyseal femoral fractures have been observed during long-term bisphosphonate therapy.

Important precautions: Fosamax is contraindicated in patients with esophageal abnormalities that delay esophageal emptying (such as strictures or achalasia), inability to stand or sit upright for at least 30 minutes, or severe renal impairment defined by a creatinine clearance under 35 mL/min. It must not be administered to patients with uncorrected hypocalcemia. Safety and effectiveness in pediatric populations have not been established. Patients undergoing invasive dental procedures should inform their dentist, as dental surgery can trigger localized osteonecrosis of the jaw.

Red flags: Seek prompt emergency medical evaluation if you develop severe difficulty swallowing, pain when swallowing, retrosternal chest pain, or severe skin rash or swelling. Signs of profound hypocalcemia–such as muscle spasms, twitches, or tingling sensations around the mouth or in the fingers–require immediate clinical management. Additionally, report any persistent, unexplained thigh, groin, or hip pain to a physician promptly, as this may precede an atypical femoral fracture.

If you skip a dose: For once-weekly dosing schedules, if a dose is forgotten on the scheduled morning, take one tablet on the morning after the missed dose is remembered. Do not take two tablets on the same day. Resume your standard weekly schedule on the chosen day of the week. For once-daily formulations, skip the missed dose entirely and resume your regular dosing schedule the following morning. Never double the dose to compensate for a skipped tablet.

Common Questions

Can Fosamax be taken at bedtime instead of the morning?

No. Taking Fosamax at bedtime or while lying down substantially increases the risk of severe esophageal irritation, mucosal ulceration, and erosion. The medication must strictly be taken immediately after getting out of bed in the morning, while remaining in an upright position for at least 30 minutes.

How long is treatment with Fosamax typically continued?

The optimal duration of treatment varies based on fracture risk profile and individual bone mineral density response. Physicians frequently re-evaluate therapy after 3 to 5 years of continuous use to determine whether a temporary treatment holiday is appropriate for patients at low-to-moderate risk of fracture.

What should be done if stomach pain occurs after starting therapy?

Patients should discontinue Fosamax and contact their healthcare provider immediately if they experience new or worsening upper gastrointestinal symptoms, such as heartburn, severe stomach pain, or difficulty swallowing. Continuing treatment under these conditions can exacerbate mucosal ulceration.

Is routine calcium and vitamin D supplementation required?

Adequate intake of calcium and vitamin D is essential for maintaining bone mineralization during therapy. However, oral calcium supplements must be ingested at least 30 to 60 minutes after taking Fosamax to prevent interference with drug absorption.

Does Fosamax affect healing after dental procedures?

In rare instances, patients taking bisphosphonates may experience osteonecrosis of the jaw, particularly after invasive dental procedures such as tooth extractions or bone surgery. Routine preventative dental examinations and good oral hygiene are recommended prior to starting therapy.

In accordance with FDA requirements.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

35 mg

,

70mg

Package

12 pills

,

24 pills

,

30 pills

,

36 pills

,

48 pills

,

60 pills

,

90 pills

,

96 pills

,

120 pills

Ενεργός Ουσία